Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center…
| Price | $109.08 |
|---|---|
| Market cap | $4.96B |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Exchange | NYSE |
| 52-week range | 47.32-110.45 |
| Beta | 0.54 |
Explore HAE's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.